Russell Pearson is the AI Regulatory Policy and Projects Lead at the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), where he leads national efforts to ensure the safe and effective integration of artificial intelligence in healthcare. With over 12 years of experience across public and private sectors, he has focused on advancing innovative medical device technologies within regulated markets. He holds a master’s degree in Materials Engineering with a specialisation in biology and a PhD in nanoparticle-based drug delivery. At MHRA, he oversees the regulation of AI as a Medical Device (AIaMD), manages the agency’s regulatory sandbox for AI, and contributes to the development of the Artificial Intelligence and Digital Regulations Service (AIDRS), a key framework supporting responsible AI deployment. He also chairs the AI working group for the International Medical Device Regulators Forum (IMDRF), promoting global collaboration and alignment on regulatory practices for AI-driven medical devices.